This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1aye
From Proteopedia
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
| - | The three-dimensional structure of human procarboxypeptidase A2 has been, determined using X-ray crystallography at 1.8 A resolution. This is the, first detailed structural report of a human pancreatic carboxypeptidase, and of its zymogen. Human procarboxypeptidase A2 is formed by a, pro-segment of 96 residues, which inhibits the enzyme, and a, carboxypeptidase moiety of 305 residues. The pro-enzyme maintains the, general fold when compared with other non-human counterparts. The globular, part of the pro-segment docks into the enzyme moiety and shields the S2-S4, substrate binding sites, promoting inhibition. Interestingly, important, differences are found in the pro-segment which allow the identification of, the structural determinants of the diverse activation behaviours of, ... | + | The three-dimensional structure of human procarboxypeptidase A2 has been, determined using X-ray crystallography at 1.8 A resolution. This is the, first detailed structural report of a human pancreatic carboxypeptidase, and of its zymogen. Human procarboxypeptidase A2 is formed by a, pro-segment of 96 residues, which inhibits the enzyme, and a, carboxypeptidase moiety of 305 residues. The pro-enzyme maintains the, general fold when compared with other non-human counterparts. The globular, part of the pro-segment docks into the enzyme moiety and shields the S2-S4, substrate binding sites, promoting inhibition. Interestingly, important, differences are found in the pro-segment which allow the identification of, the structural determinants of the diverse activation behaviours of, procarboxypeptidases A1, B and A2, particularly of the latter. The, benzylsuccinic inhibitor is able to diffuse into the active site of, procarboxypeptidase A2 in the crystals. The structure of the, zymogen-inhibitor complex has been solved at 2.2 A resolution. The, inhibitor enters the active site through a channel formed at the interface, between the pro-segment and the enzyme regions and interacts with, important elements of the active site. The derived structural features, explain the intrinsic activity of A1/A2 pro-enzymes for small substrates. |
==About this Structure== | ==About this Structure== | ||
| - | 1AYE is a | + | 1AYE is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ZN as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Carboxypeptidase_A2 Carboxypeptidase A2], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.17.15 3.4.17.15] Structure known Active Site: 1. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1AYE OCA]. |
==Reference== | ==Reference== | ||
| Line 25: | Line 25: | ||
[[Category: zymogen]] | [[Category: zymogen]] | ||
| - | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 5 15:34:57 2007'' |
Revision as of 13:29, 5 November 2007
|
HUMAN PROCARBOXYPEPTIDASE A2
Overview
The three-dimensional structure of human procarboxypeptidase A2 has been, determined using X-ray crystallography at 1.8 A resolution. This is the, first detailed structural report of a human pancreatic carboxypeptidase, and of its zymogen. Human procarboxypeptidase A2 is formed by a, pro-segment of 96 residues, which inhibits the enzyme, and a, carboxypeptidase moiety of 305 residues. The pro-enzyme maintains the, general fold when compared with other non-human counterparts. The globular, part of the pro-segment docks into the enzyme moiety and shields the S2-S4, substrate binding sites, promoting inhibition. Interestingly, important, differences are found in the pro-segment which allow the identification of, the structural determinants of the diverse activation behaviours of, procarboxypeptidases A1, B and A2, particularly of the latter. The, benzylsuccinic inhibitor is able to diffuse into the active site of, procarboxypeptidase A2 in the crystals. The structure of the, zymogen-inhibitor complex has been solved at 2.2 A resolution. The, inhibitor enters the active site through a channel formed at the interface, between the pro-segment and the enzyme regions and interacts with, important elements of the active site. The derived structural features, explain the intrinsic activity of A1/A2 pro-enzymes for small substrates.
About this Structure
1AYE is a Single protein structure of sequence from Homo sapiens with ZN as ligand. Active as Carboxypeptidase A2, with EC number 3.4.17.15 Structure known Active Site: 1. Full crystallographic information is available from OCA.
Reference
The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen., Garcia-Saez I, Reverter D, Vendrell J, Aviles FX, Coll M, EMBO J. 1997 Dec 1;16(23):6906-13. PMID:9384570
Page seeded by OCA on Mon Nov 5 15:34:57 2007
